Healthcare professionals give intradermal injections just below the surface of the skin, creating a small bump called a bleb or wheal. The intradermal injection route has the longest absorption time ...
Subcutaneous nivolumab and hyaluronidase-nvhy is FDA-approved for adult solid tumors, offering a new administration route for PD-1 inhibitors. The phase 3 CheckMate-67T trial confirmed noninferiority ...
Keytruda Qlex, a subcutaneous formulation, is FDA-approved for solid tumors in patients 12 and older, offering an alternative to intravenous administration. Study MK-3475A-D77 showed comparable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback